medigraphic.com
ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio

2014, Number 11-12

<< Back

Medicina & Laboratorio 2014; 20 (11-12)

Ristocetin cofactor

Language: Spanish
References: 7
Page: 579-584
PDF size: 438.52 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Rodeghiero F. Von Willebrand disease: pathogenesis and management. Thromb Res 2013; 131 Suppl 1: S47-50.

  2. Nichols WL, Hultin MB, James AH, Manco- Johnson MJ, Montgomery RR, Ortel TL, et al. von Willebrand disease (VWD): evidencebased diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14: 171-232.

  3. Castaman G, Goodeve A, Eikenboom J. Principles of care for the diagnosis and treatment of von Willebrand disease. Haematologica 2013; 98: 667-674.

  4. Helena Laboratories. Ristocetin cofactor assay. Cat. No. 5370. Texas, Estados Unidos. Disponible: http://www.helena.com/Procedures/ Pro064Rev5.pdf. Consultado: septiembre 2014.

  5. Greer JP, Arber DA, Glader B, List AF, Means RTJ, Paraskevas F, et al. Wintrobe’s Clinical Hematology. Filadelfia, Estados Unidos: Lippincott Williams & Wilkins; 2014.

  6. Favaloro EJ. Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions. Semin Thromb Hemost 2014; 40: 551-570.

  7. Lipe BC, Dumas MA, Ornstein DL. Von Willebrand disease in pregnancy. Hematol Oncol Clin North Am 2011; 25: 335-358, viii.




2020     |     www.medigraphic.com